Heart Test Laboratories Inc Common Stock (HSCS) had the highest return between May 20, 2022 and October 1, 2022 by a US stock, returning 346,958.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Heart Test Laboratories Inc Common Stock (HSCS) | 5/20/2022 - 10/1/2022 | 346,958.82% |
Rhythm Pharmaceuticals (RYTM) | 5/20/2022 - 10/1/2022 | 670.44% |
Pliant Therapeutics (PLRX) | 5/20/2022 - 10/1/2022 | 303.28% |
AMTD Digital (HKD) | 5/20/2022 - 10/1/2022 | 260% |
Alaunos Therapeutics (TCRT) | 5/20/2022 - 10/1/2022 | 258.33% |
Bioatla (BCAB) | 5/20/2022 - 10/1/2022 | 233.33% |
Cogent Biosciences (COGT) | 5/20/2022 - 10/1/2022 | 225.05% |
Immuneering (IMRX) | 5/20/2022 - 10/1/2022 | 213.35% |
Amylyx Pharmaceuticals (AMLX) | 5/20/2022 - 10/1/2022 | 207.99% |
Minerva Neurosciences (NERV) | 5/20/2022 - 10/1/2022 | 196.59% |
TherapeuticsMD (TXMD) | 5/20/2022 - 10/1/2022 | 193.81% |
Acumen Pharmaceuticals (ABOS) | 5/20/2022 - 10/1/2022 | 180.95% |
Wave Life Sciences (WVE) | 5/20/2022 - 10/1/2022 | 179.84% |
ZW Data Action Technologies (CNET) | 5/20/2022 - 10/1/2022 | 179.33% |
Heartbeam (BEAT) | 5/20/2022 - 10/1/2022 | 178.57% |
Belite Bio Inc ADR (BLTE) | 5/20/2022 - 10/1/2022 | 175.45% |
XChange TECINC (XHG) | 5/20/2022 - 10/1/2022 | 163.71% |
Altimmune (ALT) | 5/20/2022 - 10/1/2022 | 157.98% |
Entrada Therapeutics (TRDA) | 5/20/2022 - 10/1/2022 | 154.19% |
Yatsen (YSG) | 5/20/2022 - 10/1/2022 | 142.22% |
Dyne Therapeutics (DYN) | 5/20/2022 - 10/1/2022 | 130.49% |
Prothena (PRTA) | 5/20/2022 - 10/1/2022 | 125.39% |
Sobr Safe (SOBR) | 5/20/2022 - 10/1/2022 | 117.89% |
United Maritime (USEA) | 5/20/2022 - 10/1/2022 | 116.24% |
Baosheng Media (BAOS) | 5/20/2022 - 10/1/2022 | 115.01% |